Agios Pharmaceuticals, Inc. (LON:0HB0)
London
· Delayed Price · Currency is GBP · Price in USD 34.74
+1.03 (3.06%)
At close: Feb 21, 2025
Agios Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 76.25 | 88.21 | 139.26 | 203.13 | 127.44 | Upgrade
|
| Short-Term Investments | 817.46 | 688.72 | 643.86 | 816.89 | 445.49 | Upgrade
|
| Cash & Short-Term Investments | 893.71 | 776.93 | 783.12 | 1,020 | 572.93 | Upgrade
|
| Cash Growth | 15.03% | -0.79% | -23.22% | 78.04% | 1.43% | Upgrade
|
| Accounts Receivable | 4.11 | 2.81 | 2.21 | - | - | Upgrade
|
| Other Receivables | - | 1.1 | 0.3 | 7.28 | - | Upgrade
|
| Receivables | 4.11 | 3.91 | 2.51 | 7.28 | - | Upgrade
|
| Inventory | 27.62 | 19.08 | 8.49 | - | - | Upgrade
|
| Prepaid Expenses | 40.17 | 33.92 | 38.66 | 36.94 | 15.89 | Upgrade
|
| Other Current Assets | - | - | - | - | 47.86 | Upgrade
|
| Total Current Assets | 965.6 | 833.84 | 832.77 | 1,064 | 636.68 | Upgrade
|
| Property, Plant & Equipment | 54.55 | 69.79 | 88.12 | 104.23 | 116.07 | Upgrade
|
| Long-Term Investments | 638.32 | 29.44 | 313.87 | 266.38 | 97.61 | Upgrade
|
| Other Long-Term Assets | 4.72 | 4.06 | 3.96 | 2.9 | 2.6 | Upgrade
|
| Total Assets | 1,663 | 937.12 | 1,239 | 1,438 | 852.95 | Upgrade
|
| Accounts Payable | 16.64 | 9.78 | 18.62 | 16.7 | 17.72 | Upgrade
|
| Accrued Expenses | 46.86 | 43.17 | 30.35 | 31.97 | 30.8 | Upgrade
|
| Current Portion of Leases | 16.78 | 15.01 | 13.66 | 11.16 | 7.41 | Upgrade
|
| Current Income Taxes Payable | 0.87 | - | - | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | 38.46 | Upgrade
|
| Total Current Liabilities | 81.16 | 67.96 | 62.63 | 59.83 | 94.39 | Upgrade
|
| Long-Term Leases | 40.21 | 56.99 | 72 | 85.94 | 97.79 | Upgrade
|
| Other Long-Term Liabilities | 0.88 | 1.16 | 3.28 | - | 261.27 | Upgrade
|
| Total Liabilities | 122.24 | 126.1 | 137.9 | 145.76 | 453.45 | Upgrade
|
| Common Stock | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Additional Paid-In Capital | 2,494 | 2,437 | 2,386 | 2,334 | 2,243 | Upgrade
|
| Retained Earnings | -148.92 | -822.65 | -470.56 | -238.76 | -1,843 | Upgrade
|
| Treasury Stock | -802.49 | -802.49 | -802.49 | -802.49 | - | Upgrade
|
| Comprehensive Income & Other | -1.52 | -0.44 | -12.54 | -1.2 | 0.11 | Upgrade
|
| Shareholders' Equity | 1,541 | 811.02 | 1,101 | 1,292 | 399.5 | Upgrade
|
| Total Liabilities & Equity | 1,663 | 937.12 | 1,239 | 1,438 | 852.95 | Upgrade
|
| Total Debt | 56.99 | 72 | 85.66 | 97.09 | 105.2 | Upgrade
|
| Net Cash (Debt) | 1,475 | 734.37 | 1,011 | 1,189 | 565.34 | Upgrade
|
| Net Cash Growth | 100.86% | -27.39% | -14.96% | 110.37% | -6.42% | Upgrade
|
| Net Cash Per Share | 25.48 | 13.20 | 18.46 | 19.67 | 8.19 | Upgrade
|
| Filing Date Shares Outstanding | 57.3 | 56.19 | 55.29 | 54.64 | 69.6 | Upgrade
|
| Total Common Shares Outstanding | 57.16 | 55.95 | 55.04 | 54.33 | 69.29 | Upgrade
|
| Working Capital | 884.44 | 765.88 | 770.14 | 1,004 | 542.28 | Upgrade
|
| Book Value Per Share | 26.96 | 14.50 | 20.00 | 23.78 | 5.77 | Upgrade
|
| Tangible Book Value | 1,541 | 811.02 | 1,101 | 1,292 | 399.5 | Upgrade
|
| Tangible Book Value Per Share | 26.96 | 14.50 | 20.00 | 23.78 | 5.77 | Upgrade
|
| Machinery | 29.76 | 29.73 | 35.12 | 33.8 | 35.49 | Upgrade
|
| Construction In Progress | 0.9 | 0.61 | 0.66 | 7.37 | 4.11 | Upgrade
|
| Leasehold Improvements | 37.52 | 37.28 | 37.28 | 32.73 | 32.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.